Investor FAQs | Tempest Therapeutics

When was Tempest founded?

Tempest was founded in 2011 and incubated by Versant Ventures, and emerged as Tempest in 2017

Where is Tempest headquartered?

Tempest’s corporate offices are located at:
7000 Shoreline Court
Suite 275
South San Francisco, CA 94080

When did Tempest go public?

In June 2021 via a reverse merger transaction.

On what stock exchange and under what symbol are Tempest shares traded?

Tempest is listed under the Nasdaq Global Market under the ticker symbol TPST

Who do I contact with inquiries related to my stock, such as address changes, transferring stock, or replacing lost stock certificates?

Please contact Tempest’s transfer agent:
Computershare
33 N. LaSalle St, Suite 1100
Chicago, IL 60602
Ginger.Lawrence@computershare.com
(312) 588-4738

Does Tempest have a direct stock purchase plan?

Tempest does not offer a direct stock purchase plan. Tempest stock may be purchased through a licensed securities broker.

Does Tempest issue dividends on its common stock?

Tempest does not pay cash dividends on its common stock and does not anticipate doing so in the foreseeable future.

What is the Tempest CUSIP number?

The Tempest CUSIP number is 87978U 108

Who is an external legal counsel for Tempest?

Cooley
3175 Hanover Street
Palo Alto, CA 94304-1130
650-843-5000

Who is Tempest’s independent auditors?

Ernst & Young
1 Manhattan West
395 9th Ave, New York, NY 10001
212 773 3000

Where do I find Form 8937?

Form 8937 – Tempest

Form 8937 – Millendo

When is the company’s fiscal year end?

Tempest’s fiscal year end is December 31st

Who can I contact for more information?

For more information on Tempest, please contact Investor Relations here.